Meropenem Injection, Powder, For Solution
Product Images NDC 55150-207

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Meropenem (NDC 55150-207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (500 mg/vial)

Package Label-principal Display Panel (500 mg/vial)
This seems to be a product description for an intravenous medication called Meropenem, indicating its NDC code and sodium content. Dosage and administration instructions are also provided, advising users to refer to the accompanying prescribing information and to store the medication in specific temperature conditions. The text also mentions the product's sterility and manufacturer details.*
FDA Label Image

Package Label-principal Display Panel (500 mg/vial)

Package Label-principal Display Panel (500 mg/vial)
The text is a description of Meropenem for injection, USP (1.V.) a medication for Intravenous use. It comes in sterile 10 x 500 mg sterile vials. The text includes dosage and prescribing information, storage recommendations, and the manufacturer's information.*
FDA Label Image

Package Label-principal Display Panel (1 g/vial)

Package Label-principal Display Panel (1 g/vial)
This is a description of a medication called Pyrooenfree, with the NDC code 55150-208-30. Each vial contains leropenem, which is equivalent to 1 g of meropenem activity. The medication is for intravenous use only and needs to be prepared according to the accompanying prescribing information. The text gives instructions for storage and after constitution. This medication is distributed by AuroMedics Pharma LLP in India.*
FDA Label Image

Package Label-principal Display Panel (1 g/vial)

Package Label-principal Display Panel (1 g/vial)
This is a description of Meropenem for Injection, USP (I.V.), used for intravenous medical treatment. It comes in 10 sterile vials, each containing 1 gram of the drug, equivalent to 101 g of meropenem ety, and is manufactured by AuroMedis Pharma. The dosage and administration information can be found in the accompanying Prescribing Information. Prior to administration, it should be stored at a controlled room temperature of 20-25°C. The VL stoppers are made with natural rubber latex. Sodium content for this medication is 802mg (3.92%). The textual contents do not meet English language requirements.*
FDA Label Image

Chemical Structure (Meropenem Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.